DailyDoctor Archive Specialties Get app
Back to the 17 October 2026 edition

Practice changer · 05 of 05

Lichen planus: cancer risk follows the site of disease

Plan site-matched follow-up for oral and genital lichen planus and biopsy any persistent change, while explaining that absolute risk stays low.

Design
Nationwide register-based retrospective cohort
Population
35,845 Danish patients with incident lichen planus and no prior cancer
Primary outcome
Cancer incidence compared with the general population
Effect
Women: oral cavity SIR 7.5 (95% CI 6.4 to 8.9); vulva 2.6 (2.0 to 3.4); 20-year oral cavity risk 0.8%

A Danish nationwide register cohort followed 35,845 people with a new diagnosis of lichen planus from 1978 to 2020, all without previous cancer, and compared their cancer rates with the general population. Published in JAMA Dermatology on 14 October 2026.

In women, rates were raised for cancers of the lip (standardised incidence ratio 6.0, 95% CI 3.3 to 10.0), oral cavity (7.5, 6.4 to 8.9) and tongue (6.8, 5.4 to 8.4), and for vulval cancer (2.6, 2.0 to 3.4). Cutaneous squamous cell carcinoma was slightly raised (1.4). Men showed a similar pattern. Oral cancer risk was highest in people with oral lichen planus, and genital cancer risk in those with genital disease. The 20-year absolute risk of oral cavity cancer was 0.8% in women and 1.0% in men; of genital cancer, 0.4% and 0.2%.

This is observational, and some excess may reflect closer examination of people already under follow-up. But the site-specific pattern is consistent and supports a follow-up plan matched to where the disease is, rather than discharging patients once skin lesions settle. In India, where tobacco and areca nut use add to oral cancer risk, the case for oral review is stronger.

  • Arrange periodic oral examination for patients with oral lichen planus, with dental or oral medicine input
  • Arrange periodic genital review for patients with genital lichen planus
  • Biopsy any non-healing ulcer, thickened plaque or changing area at an affected site
  • Advise stopping tobacco and areca nut, which add to oral cancer risk
  • Explain that absolute risk is low, around 1% over 20 years for oral cancer

Why it matters

Discharging a patient once skin lesions fade leaves mucosal disease, and its cancer risk, unwatched.

Don't overread it

This is an association from register data; it does not establish a follow-up interval or show that surveillance saves lives.

The statistics, in plain English

A standardised incidence ratio of 7.5 means about seven and a half times as many oral cavity cancers as expected in the general population. Because these cancers are rare, that still translates into an absolute 20-year risk of about 1 in 100.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

skincanceracneproceduralderm

Tomorrow morning, before your first patient

One edition a day for dermatology, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free
Daily Doctor All 27 specialties, every morning. Free.
Get the app